Sodium phenylacetate inhibits adoptive transfer of experimental allergic encephalomyelitis in SJL/J mice at multiple steps

Journal of Immunology

Volumn 170, Issue 7, 2003, Pages 3874-3882

  Dasgupta, Subhajit ^a   Zhou, You ^b   Jana, Malabendu ^a   Banik, Naren L ^c   Pahan, Kalipada ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 NITROTYROSINE; ARYLBUTYRIC ACID DERIVATIVE; DRINKING WATER; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYELIN BASIC PROTEIN; NITRIC OXIDE SYNTHASE; PHENYLACETATE SODIUM; PHENYLACETIC ACID DERIVATIVE; SODIUM PHENYLBUTYRATE; SYNAPTOTAGMIN; UNCLASSIFIED DRUG;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME ACTIVATION; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; MICROGLIA; MONONUCLEAR CELL; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SPINAL CORD; T LYMPHOCYTE; UREA CYCLE;

EID: 0347296187     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.7.3874     Document Type: Article

References (34)

1. Martin, R., H. F. McFarland, and D. E. McFarlin. 1992. Immunological aspects of demyelinating diseases. Annu. Rev. Immunol. 10:153.
2. Tuohy, V. K., R. A. Sobel, and M. B. Less. 1988. Myelin proteolipid proteininduced experimental allergic encephalomyelitis. J. Immunol. 140:1868.
3. Benveniste, E. N. 1997. Role of macrophages/microglia in multiple sclerosis and experimental allergic encephalomyelitis. J. Mol. Med. 75:165.
4. Du, C., M. W. Khalil, and S. Sriram. 2001. Administration of dehydroepiandrosterone suppresses experimental allergic encephalomyelitis in SJL/J mice. J. Immunol. 167:7094.
5. Parkinson, J. F., B. Mitrovic, and J. E. Merrill. 1997. The role of nitric oxide in multiple sclerosis. J. Mol. Med. 75:174.
6. Pahan, K., and M. Schmid. 2000. Activation of NF-κB in the spinal cord of experimental allergic encephalomyelitis. Neurosci. Lett. 287:17.
7. Batshaw, M. L., and S. W. Brusilow. 1981. Evidence of lack of toxicity of sodium phenylacetate and sodium benzoate in treating urea cycle enzymopathies. J. Inherited Metab. Dis. 4:231.
8. Pahan, K., F. G. Sheikh, A. M. S. Namboodiri, and I. Singh. 1997. Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes, microglia, and macrophages. J. Clin. Invest. 100:2671.
9. Dasgupta, S., M. Jana, X. Liu, and K. Pahan. 2002. Myelin basic protein (MBP)primed T cells induce nitric oxide synthase in microglial cells: implications for multiple sclerosis. J. Biol. Chem. 277:39327.
10. Galea, E., D. L. Feinstein, and D. J. Reis. 1992. Induction of calcium-independent nitric oxide synthase activity in primary rat glial cultures. Proc. Natl. Acad. Sci. USA 89:10945.
11. Pahan, K., A. M. S. Namboodiri, F. G. Sheikh, B. T. Smith, and I. Singh. 1997. Increasing cAMP attenuates induction of inducible nitric oxide synthase in rat primary astrocytes. J. Biol. Chem. 272:7786.
12. ras inhibits induction of nitric oxide synthase and activation of NF-κB and in primary astrocytes. J. Neurochem. 74:2288.
13. Pahan, K., F. G. Sheikh, X. Liu, S. Hilger, M. McKinney, and T. M. Petro. 2001. Interleukin-12 p40 induces nitric oxide synthase and activates NF-κB in microglial cells. J. Biol. Chem. 276:7899.
14. Jana, M., X. Liu, S. Koka, S. Ghosh, T. M. Petro, and K. Pahan. 2001. Ligation of CD40 stimulates the induction of nitric oxide synthase in microglial cells. J. Biol. Chem. 276:44527.
15. Dignam, J. D., R. M. Lebovitz, and R. G. Roeder. 1983. Accurate transcription initiation by RNA polymerase I1 in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1475.
16. Liu, X., M. Jana, S. Dasgupta, S. Koka, J. He, C. Wood, and K. Pahan. 2002. Human immunodeficiency virus type 1 (HIV-1) tat induces nitric-oxide synthase in human astroglia. J. Biol. Chem. 277:39312.
17. Pahan, K., M. Jana, X. Liu, B. S. Taylor, C. Wood, and S. M. Fischer. 2002. Gemfibrozil, a lipid-lowering drug, inhibits the induction of nitric-oxide synthase in human astrocytes. J. Biol. Chem. 277:45984.
18. Xie, Q. W., Y. Kashiwabara, and C. Nathan. 1994. Role of transcription factor NF-κB/Rel in induction of nitric oxide synthase. J. Biol. Chem. 269:4705.
19. Maestri, N. E., S. W. Brusilow, D. B. Clissold, and S. S. Bassett. 1996. Long-term treatment of girls with ornithine transcarbamylase deficiency. N. Engl. J. Med. 335:855.
20. Koprowski, H., S. V. Spitsin, and D. C. Hooper. 2001. Prospects for the treatment of multiple sclerosis by raising serum levels of uric acid, a scavenger of peroxynitrite. Ann. Neurol. 49:139.
21. Hilliard, B., E. B. Samoilova, T. S. Liu, A. Rostami, and Y. Chen. 1999. Experimental autoimmune encephalomyelitis in NF-κB-deficient mice: roles of NF-κB in the activation and differentiation of autoreactive T cells. J. Immunol. 163:2937.
22. Weller, R. O., B. Engelhardt, and M. J. Phillips. 1996. Lymphocyte targeting of the central nervous system: a review of afferent and efferent CNS-immune pathways. Brain Pathol. 6:275.
23. Thiel, V. E., and K. L. Audus. 2001. Nitric oxide and blood-brain barrier integrity. Antioxid. Redox Signal. 3:273.
24. Hurst, R. D., S. Azam, A. Hurst, and J. B. Clark. 2001. Nitric oxide-induced inhibition of glyceraldehyde-3-phosphate dehydrogenase may mediate reduced endothelial cell monolayer integrity in an in vitro model blood-brain barrier. Brain Res. 894:181.
25. Ghosh, S. 1999. Regulation of inducible gene expression by the transcription factor NF-κB. Immunol. Res. 19:183.
26. Bo, L., T. M. Dawson, S. Wesselingh, S. Mork, S. Choi, P. A. Kong, D. Hanley, and B. D. Trapp. 1994. Induction of nitric oxide synthase in demyelinating regions of multiple sclerosis brains. Ann. Neurol. 36:778.
27. Merrill, J. E., L. J. Ignarro, M. P. Sherman, J. Melinek, and T. E. Lane. 1993. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J. Immunol. 151:2132.
28. Jaffrey, S. R., and S. H. Snyder. 1995. Nitric oxide: a neural messenger. Annu. Rev. Cell. Dev. Biol. 11:417.
29. Touil, T., M. S. Deloire-Grassin, C. Vital, K. G. Petry, and B. Brochet. 2001. In vivo damage of CNS myelin and axons induced by peroxynitrite. NeuroReport 12:3637.
30. Fenyk-Melody, J. E., A. E. Garrison, S. R. Brunnert, J. R. Weidner, F. Shen, B. A. Shelton, and J. S. Mudgett. 1998. Experimental autoimmune encephalomyelitis is exacerbated in mice lacking the NOS2 gene. J. Immunol. 160:2940.
31. Ding, M. Z., M. Zhang, J. L. Wong, N. E. Rogers, L. J. Ignarro, and R. R. Voskuhl. 1998. Cutting edge: antisense knockdown of inducible nitric oxide synthase inhibits induction of experimental autoimmune encephalomyelitis in SJL/J mice. J. Immunol. 160:2560.
32. Allione, A., P. Bernabei, M. Bosticardo, S. Ariotti, G. Forni, and F. Novelli. 1999. Nitric oxide suppresses human T lymphocyte proliferation through IFNγ-dependent and IFN-γ-independent induction of apoptosis. J. Immunol. 163:4182.
33. Miller, A. 1997. Current and investigational therapies used to alter the course of disease in multiple sclerosis. South. Med. J. 90:367.
34. Connelly, J. F. 1994. Interferon β for multiple sclerosis. Ann. Pharmacother. 28:610.